The state of Delaware is worried that it would lose AstraZeneca's U.S. headquarters–and the thousands of jobs that go with it–should Pfizer succeed in buying the U.K. company.
written on 22.05.2014
Delaware counts the cost of a Pfizer takeover of AstraZeneca
